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Abstract
We describe a clinical case concerning a 36 year old man with a recalcitrant dermatosis involving the face and
neck to demonstrate how multiple pathogenic mechanisms may ultimately prohibit disease resolution. This patient’s
disease persisted despite multiple standard treatments for the leading differential diagnoses early in the disease
course including: topical/systemic corticosteroids for an initially suspected facial dermatitis followed by minocycline
and oral ivermectin for granulomatous rosacea with high Demodex burden. These failed therapies prompted the use
of oral prednisone and topical pimecrolimus that resulted in some improvement but worsening flares if therapy was
discontinued. The leading differential shifted toward rosacea fulminans or an unusual manifestation of immune
reconstitution inflammatory syndrome (IRIS) in the setting of possible HIV or iatrogenic immunosuppression. An
extensive diagnostic workup was completed and showed isolated IgM deficiency (49 mg/dl, normal range 60 to 300
mg/dl), low levels of 25 hydroxyvitamin D (15 pg/mL, normal range 18 to 64 pg/mL), and low ascorbic acid (0.3
mg/dl, normal range 0.6 to 2.0 mg/dl). The rash finally resolved following a tapering course of cyclosporine and
vitamin repletion through supplements and dietary alteration. Our case is one with multiple confounding variables
that may have contributed to the recalcitrant nature of this dermatosis: (1) presence of Demodex; (2) iatrogenic
immunosuppression due to prolonged systemic and topical steroid use; and (3) vitamin deficiency. It is unclear
exactly what role each of these factors played but the purpose of our case is to illustrate these variables can be
encountered in regular practice and that sometimes the physician must explore and correct all potential vectors of
pathogenesis in order to successfully treat recalcitrant dermatoses.
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Case Report
Our patient is a 36-year-old otherwise healthy male referred to
Indiana University (IU) Department of Dermatology for an 8-month
history of a recalcitrant dermatosis involving the face and neck.
He was initially treated for 5 months by his primary care physician
for a facial dermatitis of unknown etiology with multiple courses of
steroids including: 5 courses of oral prednisone, 2 cortisone
intramuscular injections, and a 3-week course of a topical steroid. The
rash failed to improve, and he was referred to an outside dermatologist
who initially treated him for rosacea with a month of minocycline and
azelaic acid in March 2013. At one-month follow up, a skin biopsy was
preformed and a thorough rheumatologic work up completed to rule
out systemic lupus; Metronidazole 1% gel was added to his regimen.
Antinuclear antibody (ANA), Anti-Sm antibody, Anti-Scl-70, Anti-SS-
A/SS-B, and erythrocyte sedimentation rate (ESR) were all within
normal limits; skin biopsy showed spongiosis with a chronic
perivascular dermal inflammatory infiltrate. At his May 2013 visit,
patch testing revealed reactions to bacitracin and neomycin but these
were not believed to be relevant to the current dermatitis. Therapy
with topical pimecrolimus 1% cream and a single injection of
intramuscular triamcinolone were initiated and he was then referred
to IU for further evaluation and more extensive patch testing.
At his initial visit with IU Dermatology on July 29, 2013, he was
noted to have an edematous and erythematous scaling papular
eruption on his face that extended to both sides of the neck including
Wilkinson’s triangle, but sparing the nose (Figure 1). With this
distribution, airborne contact dermatitis was initially entertained but
patch testing with North American and fragrance series was negative.
Figure 1: Erythematous and edematous face and neck consistent of
discrete and coalescing papules and pustules.
On July 3 he returned with a more extensive and increasingly
erythematous rash studded with numerous pustules that raised
suspicion for steroid induced rosacea due to discontinuation of the
oral steroid 10 days prior. A pustule on the neck was scraped and
revealed numerous Demodex organisms on microscopy (Figure 2).
Therapy was initiated with oral ivermectin 15 mg on day 1 and 7 and
doxycycline 100 mg daily. Over the next 3 months, the patient
returned to clinic on multiple occasions for persistent and at times
Journal of Clinical & Experimental
Dermatology Research Wilson et al., J Clin Exp Dermatol Res 2015, 6:5http://dx.doi.org/10.4172/2155-9554.10000298
Case Report Open Access
J Clin Exp Dermatol Res
ISSN:2155-9554 JCEDR an open access journal Volume 6 • Issue 5 • 10000298
worsening inflammation. Eventually, he was given a 3-month course
of prednisone with slow taper and isotretinoin 30 mg daily.
Figure 2: High power view of 10 Demodex mites on skin scraping.
On November one day after completion of prednisone, the patient
flared. At this point, there were growing concerns for rosacea
fulminans or an unusual manifestation of immune reconstitution
inflammatory syndrome (IRIS) in the setting of possible HIV or
iatrogenic immunosuppression. An extensive diagnostic workup was
completed and included a second skin scraping that again
demonstrated Demodex organisms (Figure 2). Laboratory results
showed isolated IgM deficiency (49 mg/dl, normal range 60 to 300 mg/
dl), low levels of cholecalciferol (15 pg/mL, normal range 18 to 64 pg/
mL), and low ascorbic acid (0.3 mg/dl, normal range 0.6 to 2.0 mg/dl).
Zinc, HIV, H. pylori, TSH, IgA, and IgG were within normal limits.
Biopsies taken from the left upper chest demonstrated subtle
spongiosis with focal granulomatous perifolliculitis, consistent with
granulomatous rosacea. A cyclosporine 50 mg taper (five day intervals
starting with thrice daily then twice daily, and finishing with
approximately 2 weeks of daily medication) and Ivermectin 3 mg daily
for 3 weeks was initiated along with ascorbic acid 500 mg and
cholecalciferol 1000 units daily to assist with vitamin repletion. After 4
weeks of therapy, the patient had significant improvement on physical
exam showing only small residual patches of erythema involving
glabella, eyebrows, and bilateral cheeks. IgM levels returned to normal.
Cyclosporin was tapered to 50 mg every other day for four doses then
every third day for three doses and ivermectin was discontinued. He
continued with vitamin supplementation daily and dietary changes,
including daily intake of green smoothies, and at his 6 month follow
up his skin was clear without any evidence of inflammation (Figure 3).
Figure 3: Resolution of recalcitrant dermatosis following, Demodex
treatment, tapering of immunosuppressives, and nutritional
supplementation.
Discussion
The clinical manifestations of rosacea are hypothesized to be the
result of a dysregulation of the innate immune system that begins with
increased toll like receptor 2 (TLR2) expression [1]. TLR2 stimulates
production of kallikrein 5, a serine protease that abnormally processes
the antimicrobial peptide cathelicidin into a larger molecular weight
form compared to that of normal epidermis. This abnormal form,
LL-37, contributes to the inflammation and flushing seen in rosacea by
increasing leukocyte chemotaxis and angiogenesis [2]. Additionally, it
has a lower antimicrobial power compared to normally processed
molecules [3].
Demodex folliculorum and Demodex brevis are two mite species
known to be obligatory parasites found in hair follicles and
pilosebaceous glands, particularly concentrated on the scalp, face, and
upper chest. A higher concentration of mites are found in the skin of
patients with papulopustular rosacea (PPR) and it has been
hypothesized that Demodex may contribute to its pathogenesis. One
proposed mechanism is that Demodex infection is due to an initial
immune defect, innate or acquired, that allows for organism
proliferation. After months to years, the mites induce epithelial barrier
disruption and via chitin activate TLR2 which enhances proteolytic
cleavage of cathelicidins into the LL-37 form contributing to the
pathogenesis of rosacea [3,4].
Now the question arises, what allowed for proliferation of Demodex
mites in an otherwise young, healthy individual? The highest rate of
Demodex infestation occurs in the second and third decade of life,
likely due to increased sebum secretion, but it is an underlying
immune suppression, either primary or acquired, that allows for the
development of clinical disease [5]. In our patient, multiple courses of
steroids were used to treat his initial condition, which likely played a
role in immunosuppression. Additionally, his extremely recalcitrant
presentation elicited a comprehensive laboratory work up that
revealed deficiency in vitamin C and vitamin D both of which have
well documented roles in skin integrity and the immune response.
For innate immunity, vitamin D has an anti-inflammatory and
antimicrobial role via up-regulation of cathelicidins. Cathelicidins are
expressed in high amounts in barrier tissues and, through multiple
immune mechanisms, cause a reduction in skin inflammation,
vascular response, and secondary skin infections [6,7]. However,
patients deficient in vitamin D, specifically calcifediol levels below 20
ng/dl, may be unable to fully express cathelicidins making them
increasingly susceptible to infection secondary to barrier dysfunction
[8]. Vitamin C is well known for its role in maintaining skin integrity
and wound healing. Together these two deficiencies may have
permitted the proliferation and barrier penetration of Demodex
resulting in an inflammatory process recalcitrant to the established
treatment protocols. As for adaptive immunity, vitamin D affects T-
helper cell balance by inhibition of Th1 response while vitamin C
increases the production of IgM [9,10]. It is uncertain what role the
diminished IgM levels played in our patient but vitamin deficiency
may have contributed to his low level.
Our case has multiple confounding variables, including: (1)
presence of Demodex; (2) iatrogenic immunosuppression due to
prolonged systemic and topical steroid use; and (3) vitamin deficiency.
It is unclear exactly what role each of these factors played in our
patient’s condition. Of greater importance is that these conditions can
be commonly encountered in practice and should be individually
investigated in cases of recalcitrant dermatoses.
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It is important to note, the prevalence of Demodex induced clinical
disease is not rare in dermatology practice; however, it is often
overlooked and under diagnosed. Forton et al. [11] found an average
of 2.4 demodicoses were diagnosed per week in their observed
dermatology practices but the diagnosis varied greatly depending on
the physician and familiarity with the condition.
Secondly, iatrogenic immunosuppression can arise in dermatology
with the use of topical, injectable, or oral steroids and calcineurin
inhibitors. IRIS most commonly follows immune recovery in HIV
patients after starting highly active antiretroviral therapy; however, it
can be seen in HIV-negative patients and has been documented in
various case reports of pregnancy, stem cell and solid organ transplant
recipients, and neutropenic patients [12]. In our case, the patient was
treated with multiple courses of immunosuppressants and with each
taper the eruption flared suggesting this observation may have
represented a type of immune reconstitution reaction.
Lastly, vitamin deficiencies are not uncommon in the United States.
Approximately 7.1% of the population was vitamin deficient in the
2003-2004 National Health and Nutrition Examination Survey. The
highest concentrations of deficient individuals were men aged 20-59
with low socioeconomic status and positive smoking history [13]. For
vitamin D, Jeng et al. [8] found 66.5% of their healthy controls to have
insufficient levels. Of note, our patient was of high socioeconomic
status reiterating the point it is important to consider deficiency in any
demographic.
In conclusion, all pathogenic mechanisms must be explored and
addressed in cases of recalcitrant dermatoses; we highlight that
nutritional deficiencies, despite their controversy, may have significant
effects on the immune system and skin integrity thus complicating
cutaneous disease. For this patient, it was not enough to simply
increase the complexity of pharmacologic therapy; complete resolution
without relapse was only achieved with eradication of Demodex, slow
tapering of immunosuppressants, and vitamin repletion.
Learning Points
1. Demodex overgrowth should be evaluated for and treated in
cases of recalcitrant rosacea as it is a relatively common confounding
but reversible factor in rosacea pathogenesis.
2. Physicians should be aware that flares of cutaneous disease may
be iatrogenic and result from improper tapering of topical or systemic
immunosuppressive therapy.
3. Dermatologist should consider underlying nutrition deficiencies,
regardless of patient demographics, as they may adversely affect skin
barrier function and alter its immune response.
4. An integrative approach to medicine that is mindful of a patient’s
lifestyle encourages one to think beyond the skin as a cause of
underlying disease and empowers patients to make lifestyle changes to
better their overall health.
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